// App-Quantinova.ai

e15585 : Impact of vitamin K dosing during sorafenib treatment for hepatocellular carcinoma: Effect on ischemic tumor cell damage caused by sorafenib.

Researchers

Presenter

  • Yoshimichi Haruna

Principal Investigators

  • Noriko Hasegawa

  • Kazuho Imanaka

  • Atsuo Inoue

  • Masatoshi Kudo

Medical Centers

  • Osaka General Medical Center, Osaka, Japan

  • Kinki University Faculty of Medicine, Osaka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved